INBS

Intelligent Bio Solutions Inc.

$2.25

-1.75%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Source: Yahoo Finance
AI summary

Price & performance

1M-6.4%
3M-6.4%
YTD-78.6%
1Y-83.0%
52-week range—
Beta1.31
Full chart and returns against a benchmark

Q-Score

32/ 100

Quality against peers; 50 is the peer median.

Growth37
Risk29
Performance47
Valuation38
Profitability31
Leverage27
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$4.2M+38.1%
Net income-$12.4M
Net margin-294.9%+51.3 pts
Historical fundamentals

Red flags in filings

2active red flags
Going-concern doubtAug 19, 2026
Exchange listing noticeDec 16, 2025
Filings, findings and the timeline

Revenue exposure

United Kingdom99%
Other Country1%
Asia Pacific0%
Largest customer5%
Regions, segments, customers and suppliers

Valuation

INBSIndustryP/E—29.61P/S1.773.49EV/EBITDA—18.38P/B1.353.39PEG——
Dividend yield0.00%
Every valuation metric